Outcome of pregnancies in patients with anti-SSA/Ro antibodies: A study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group

Arthritis and Rheumatism

Volumn 50, Issue 10, 2004, Pages 3187-3194

  Costedoat Chalumeau, Nathalie ^a   Amoura, Zahir ^a   Lupoglazoff, Jean Marc ^b   Huong, Du Le Thi ^a   Denjoy, Isabelle ^b   Vauthier, Danièle ^a   Sebbouh, Djamel ^a   Fain, Olivier ^c   Georgin Lavialle, Sophie ^a   Ghillani, Pascale ^a   Musset, Lucile ^a   Wechsler, Bertrand ^a   Duhaut, Pierre ^d   Piette, Jean Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c HÔPITAL JEAN VERDIER   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYCHLOROQUINE; LOW MOLECULAR WEIGHT HEPARIN; PREDNISONE; RO ANTIBODY;

ADULT; ARTICLE; CONGENITAL HEART BLOCK; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; FETUS MALFORMATION; GESTATIONAL AGE; HEART RATE; HUMAN; INFANT; INFANT DISEASE; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MIXED CONNECTIVE TISSUE DISEASE; NEWBORN; PREGNANCY; PRIORITY JOURNAL; QT PROLONGATION; SINUS BRADYCARDIA; SJOEGREN SYNDROME; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ABNORMALITIES; ADULT; ANTIBODIES, ANTINUCLEAR; BRADYCARDIA; CONNECTIVE TISSUE DISEASES; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 5644300468     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20554     Document Type: Article

References (27)

1. Kitridou RC. The neonatal lupus syndrome. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 1040-59.
2. Buyon JP. Neonatal lupus: bedside to bench and back. Scand J Rheumatol 1996;25:271-6.
3. Brucato A, Franceschini F, Buyon JP. Neonatal lupus: long-term outcomes of mothers and children and recurrence rate. Clin Exp Rheumatol 1997;15:467-73.
4. Eronen M, Siren MK, Ekblad H, Tikanoja T, Julkunen H, Paavilainen T. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000;106:86-91.
5. Moak JP, Barren KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N, et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001;37:238-42.
6. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:1832-5.
7. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66.
8. Julkunen H, Kaaja R, Siren MK, Mack C, McCready S, Holthofer H, et al. Immune-mediated congenital heart block (CHB): identifying and counseling patients at risk for having children with CHB. Semin Arthritis Rheum 1998;28:97-106.
9. Cimaz R, Stramba-Badiale M, Brucato A, Catelli L, Panzeri P, Meroni PL. QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum 2000;43:1049-53.
10. Gordon PA, Khamashta MA, Hughes GR, Rosenthal E. Increase in the heart rate-corrected QT interval in children of anti-Ro-positive mothers, with a further increase in those with siblings with congenital heart block: comment on the article by Cimaz et al [letter]. Arthritis Rheum 2001;44:242-3.
11. Schwartz PJ, Montemerlo M, Facchini M, Salice P, Rosti D, Poggio G, et al. The QT interval throughout the first 6 months of life: a prospective study. Circulation 1982;66:496-501.
12. Southall DP, Richards J, Brown DJ, Johnston PG, de Swiet M, Shinebourne EA. 24-hour tape recordings of ECG and respiration in the newborn infant with findings related to sudden death and unexplained brain damage in infancy. Arch Dis Child 1980,55:7-16.
13. Montague TJ, Taylor PG, Stockton R, Roy DL, Smith ER. The spectrum of cardiac rate and rhythm in normal newborns. Pediatr Cardiol 1982;2:33-8.
14. Valimaki I, Tarlo PA. Heart rate patterns and apnea in newborn infants. Am J Obstet Gynecol 1971;110:343-9.
15. Alpay F, Celiker A, Lenk MK, Ozcan O, Tanindi S, Isik E. Ambulatory electrocardiographic monitoring in healthy newborn infants. Turk J Pediatr 1993;35:163-70.
16. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998;338:1709-14.
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
18. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al, the European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
19. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.
20. Schwartz PJ, Garson A Jr, Paul T, Stramba-Badiale M, Vetter VL, Wren C, for the European Society of Cardiology. Guidelines for the interpretation of the neonatal electrocardiogram: Eur Heart J 2002;23:1329-44.
21. Rijnbeek PR, Witsenburg M, Schrama E, Hess J, Kors JA. New normal limits for the paediatric electrocardiogram. Eur Heart J 2001;22:702-11.
22. Cimaz R, Meroni PL, Brucato A, Fesstova W, Panzeri P, Goulene K, et al. Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal autoantibodies during the first year of life in infants who had QT interval prolongation and anti-SSA/Ro positivity without congenital heart block at birth. Arthritis Rheum 2003;48:266-8.
23. Menon A, Silverman ED, Gow RM, Hamilton RM. Chronotropic competence of the sinus node in congenital complete heart block. Am J Cardiol 1998;82:1119-21.
24. Mazel JA, El-Sherif N, Buyon J, Boutjdir M. Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation 1999;99:1914-8.
25. Hu K, Qu Y, Yue Y, Boutjdir M. Functional basis of sinus bradycardia in congenital heart block. Circ Res [article online] 2004;94:e32-8.
26. EUROCAT Report 8: surveillance of congenital anomalies in Europe 1980-1999. In: Group EW, editor. EUROCAT central registry. Ulster: University of Ulster; 2002. URL: www.eurocat. ulster.ac.uk/pubdata/report8tab.html.
27. Davignon A, Rautaharju P, Boisselle E, Soumis F, Megelas M, Choquette A. Normal ECG standards for infants and children. Pediatr Cardiol 1979;1:123-31.